Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Of Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06558786
What this trial is testing

Registry for Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal-junction CancerEsophageal Cancer
Memorial Sloan Kettering Cancer Center 50
Not applicableLooking for participantsNCT00574327
What this trial is testing

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

Who this might be right for
Barrett's EsophagusGastroesophageal Reflux DiseaseEsophageal Adenocarcinoma
Midwest Biomedical Research 3,000
Not applicableNot Yet RecruitingNCT07343869
What this trial is testing

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

Who this might be right for
Superficial Esophageal CancerOesophageal AdenocarcinomaOesophageal Squamous Cell Carcinoma+1 more
Société Française d'Endoscopie Digestive 750
Early research (Phase 1)Looking for participantsNCT07359443
What this trial is testing

Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaEsophageal Adenocarcinoma (EAC)Adenocarcinoma - Gastroesophageal Junction (GEJ)
UMC Utrecht 39
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT01498289
What this trial is testing

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
SWOG Cancer Research Network 213
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Not applicableStudy completedNCT03015389
What this trial is testing

Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma

Who this might be right for
Barrett EsophagusEsophageal DysplasiaEsophageal Adenocarcinoma
CDx Diagnostics 170
Testing effectiveness (Phase 2)Study completedNCT00054873
What this trial is testing

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsAdenocarcinoma
Chiron Corporation
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00220103
What this trial is testing

Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma of Oesophagus
Royal Marsden NHS Foundation Trust 80
Not applicableLooking for participantsNCT07660627
What this trial is testing

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

Who this might be right for
Esophageal AdenocarcinomaGastric CancerPancreatic Cancer
Masaryk Memorial Cancer Institute 34
Testing effectiveness (Phase 2)Ended earlyNCT02016534
What this trial is testing

Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors

Who this might be right for
Stomach Neoplasms
Amgen 60
Testing effectiveness (Phase 2)Study completedNCT01020630
What this trial is testing

Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI

Who this might be right for
Adenocarcinoma
PD Dr Markus Möhler 91
Large-scale testing (Phase 3)UnknownNCT00002884
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Centre Hospitalier Lyon Sud 326
Not applicableUnknownNCT04194463
What this trial is testing

Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study

Who this might be right for
Esophageal AdenocarcinomaGastric Adenocarcinoma
Newcastle-upon-Tyne Hospitals NHS Trust 40
Not applicableStudy completedNCT02606396
What this trial is testing

Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer

Who this might be right for
Esophageal Adenocarcinoma
Hunter Holmes Mcguire Veteran Affairs Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00601705
What this trial is testing

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Case Comprehensive Cancer Center 61
Early research (Phase 1)Looking for participantsNCT06623396
What this trial is testing

Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Who this might be right for
Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT04669951
What this trial is testing

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Who this might be right for
Esophagus Cancer, Adenocarcinoma
Michael Patrick Achiam 100
Next Page